Skip to main content

Table 1 Comparison of baseline characteristics in case and control group

From: The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment

Variable

HIV+TB

(Cases: N = 63)

HIV+

(Controls: N = 51)

P value

Age (years) Mean, IOR a

36.5 (24-60)

37.2 (25-57)

0.67

Gender

Males

Females

49 (77.7%)

14(22.22%)

36(70.6%)

15(29.4%)

0.38

Weight(Kg)

(Mean ± S.D.)

47.58 ± 7.78

51.47 ± 9.58

0.01

BMI (kg/m 2 )

(Mean + S.D.) b

17.83 ± 4.44

19.15 ± 4.67

0.20

CD4 cell count (cells/mm 3 )

(Median, IQR)

127 (16-693)

142 (9 -252)

0.36

Viral Load (copies/ml)

(Median, IQR)

161499

(129-6080000)

Not done

-

Haemoglobin (g/dl),

(Mean + S.D.)

10.2 ± 2.08

11.5 ± 1.53

< 0.01

Bilirubin (mg/dl)

(Mean + S.D.)

0.63 ± 0.17

0.64 ± 0.21

0.93

AST (I.U)

(Mean + S.D.)

47.76 ± 39.37

38.79 ± 21.25

0.22

ALT (I.U.)

(Mean + S.D.)

37.33 ± 32.55

35.26 ± 19.84

0.74

Albumin (g/dl)

(Mean + S.D.)

3.72 ± 0.73

4.26 ± 0.57

< 0.001

  1. aInter Quartile Range
  2. bStandard deviation